Skip to main content

EverQuote Inc

For the period ended Dec 31, 2023. Filed Feb 27, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 27, 2024

EVER$28.03-1.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 8. Consolidated Statements of Cash Flows

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

Year Ended December 31,
202320222021
Cash flows from operating activities:
Net loss$(51,287)$(24,416)$(19,434)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization expense6,1965,8485,072
Stock-based compensation expense24,09628,98630,020
Loss on sale of health assets19,388——
Impairment of right-of-use asset384——
Change in fair value of contingent consideration liabilities(150)(4,135)196
Deferred taxes——(2,510)
Provision for (recovery of) bad debt204693(41)
Unrealized foreign currency transaction (gains) losses21(9)24
Changes in operating assets and liabilities, net of effects from acquisition:
Accounts receivable8,2195,36210,511
Prepaid expenses and other current assets962(2,111)1,801
Commissions receivable, current and non-current4,176(24,240)(16,871)
Operating lease right-of-use assets2,4972,6132,710
Other assets421(19)534
Accounts payable(13,411)1,124(3,968)
Accrued expenses and other current liabilities(1,543)(2,375)2,692
Deferred revenue5(229)227
Operating lease liabilities(3,006)(2,883)(2,840)
Other long-term liabilities——(934)
Net cash provided by (used in) operating activities(2,828)(15,791)7,189
Cash flows from investing activities:
Acquisition of property and equipment, including costs capitalized for development of internal-use software(3,840)(4,290)(2,862)
Proceeds from sale of health assets13,194——
Acquisition of business——(15,955)
Net cash provided by (used in) investing activities9,354(4,290)(18,817)
Cash flows from financing activities:
Proceeds from exercise of stock options9799423,615
Proceeds from private placement of common stock—15,000—
Tax withholding payments related to net share settlement(402)(100)—
Net cash provided by financing activities57715,8423,615
Effect of exchange rate changes on cash, cash equivalents and restricted cash18(27)(6)
Net increase (decrease) in cash, cash equivalents and restricted cash7,121(4,266)(8,019)
Cash, cash equivalents and restricted cash at beginning of period30,83535,10143,120
Cash, cash equivalents and restricted cash at end of period$37,956$30,835$35,101
Supplemental disclosure of noncash investing and financing information:
Acquisition of property and equipment included in accounts payable$25$60$100
Fair value of contingent consideration in connection with acquisition included in liabilities$—$—$3,784
Issuance of Class A common stock to settle contingent consideration liabilities$—$1,889$—
Issuance of Class A common stock in settlement of stock-based compensation liability$—$164$—
Operating lease liabilities arising from obtaining right-of-use assets$—$1,096$383
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents$37,956$30,835$34,851
Restricted cash (included in other assets)——250
Total cash, cash equivalents and restricted cash shown in the statement of cash flows$37,956$30,835$35,101
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.